News

By analyzing millions of messenger RNA molecules (mRNA) during the course of ALS, researchers at Stockholm University, in ...
The ALS therapy ATH-1105 entered the brain and spinal cord at dose-proportional levels in healthy volunteers, and had a good ...
Yet another biotech is facing a delay from the Food and Drug Administration as the agency reels from intense staffing cuts. | ...
ROME, AUG 19 - An Italo-US team of scientists have made a breakthrough in the early diagnosis of amyotrophic lateral ...
The U.S. Food and Drug Administration has approved the ketamine product, KETARx, for use in surgical pain management.
A Jacksonville woman's experience caring for her husband with ALS has formed a foundation to help other families fighting ...
Retired industrial arts teacher Allen Mohr was said to have saved “a lot of kids from the scrap pile,” according to a former ...
Mark Kirton, who experienced his most productive seasons of his NHL career with the Detroit Red Wings in the early 1980s, ...
SineuGene gets China NMPA & US FDA nods to initiate phase I/IIa trial of gene therapy, SNUG01 to treat amyotrophic lateral sclerosis: Beijing Monday, August 18, 2025, 18:00 Hrs [I ...
It may be time to rethink certain genetic mutations associated with two devastating neurodegenerative disorders—amyotrophic ...